Related Experiment Video
Updated: Jun 5, 2025
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines
Hasan Huseyin Kazan1, İrem Sinem Acınan2, Başak Kandemir3
1Department of Medical Biology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
Abstract:
Elimination of cytotoxic effect in cells with multidrug resistance (MDR) phenotype is a situation that is gradually acquired over time and develops through multiple pathways resulting in global phenotypic changes of cells. Although molecular background of the resistance phenotype has widely been studied in the gene expression level, segmental and gene copy number variations (CNVs) have limitedly been documented. Thus, in the present study, we aimed to analyze the CNVs using DNA microarray in the sensitive and two doxorubicin-resistant MCF-7 breast cancer cell lines which had different resistance indices. In the present study, we performed conventional karyotyping and array comparative genomic hybridization (aCGH). Then, results of aCGH data were studied with genomic profiling, comparison analysis and ideogram plotting to evaluate genomic profiles, and the loss and gains of heterozygosity profiles. Next, gene lists for each cell line were compared with the 66-breast cancer-related genes and the multidrug resistance-related genes. aCGH analyses showed that CNV profiles and the copy number of specific genes were dramatically different between these three cell lines. Totally, 6212, 6558, and 11,201 genes were found to be altered in MCF-7, MCF-7/400DOX, and MCF-7/1000DOX genomes, respectively. Amongst the MCF-7/1000DOX had the highest number of altered genes, and doxorubicin resistance may cause differential chromosomal changes depending on the resistance status. DNA microarray would be one of the informative methods used in the studies on the cancer drug resistance in addition to transcriptomic and proteomic level high throughput analysis to define molecular mechanisms of the resistance status.
Insights
Multidrug resistance (MDR) in breast cancer cells involves complex genetic changes. DNA microarrays reveal significant copy number variations (CNVs) in doxorubicin-resistant MCF-7 cells, highlighting their role in drug resistance.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Multidrug resistance (MDR) is a complex cellular phenotype acquired over time through multiple pathways.
- While gene expression in MDR is studied, segmental and copy number variations (CNVs) are less understood.
- Understanding genetic alterations is crucial for developing effective cancer therapies.
Purpose of the Study:
- To analyze copy number variations (CNVs) in sensitive and doxorubicin-resistant MCF-7 breast cancer cell lines using DNA microarray.
- To investigate the relationship between doxorubicin resistance levels and genomic alterations.
- To identify potential genomic markers associated with multidrug resistance.
Main Methods:
- Conventional karyotyping and array comparative genomic hybridization (aCGH) were performed on sensitive (MCF-7) and two doxorubicin-resistant (MCF-7/400DOX, MCF-7/1000DOX) cell lines.
- aCGH data underwent genomic profiling, comparison analysis, and heterozygosity analysis.
- Gene lists were compared against breast cancer and multidrug resistance-related gene sets.
Main Results:
- Significant differences in CNV profiles and gene copy numbers were observed between the cell lines.
- The number of altered genes was 6212 in MCF-7, 6558 in MCF-7/400DOX, and 11,201 in MCF-7/1000DOX.
- MCF-7/1000DOX exhibited the highest number of altered genes, suggesting a correlation between resistance level and chromosomal changes.
Conclusions:
- Doxorubicin resistance in breast cancer cells is associated with substantial and differential chromosomal changes.
- DNA microarray analysis is a valuable tool for studying cancer drug resistance mechanisms alongside transcriptomic and proteomic approaches.
- Identifying CNVs provides insights into the molecular basis of multidrug resistance, potentially aiding therapeutic strategies.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:56Treatment Resistant Cancers